Sign in

CIK 0000318154

  • Large accelerated filer
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
953540776
Phone
+1 805-447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
  1. 4 Shares withheld for taxes Chairman, CEO and President gave up 47,527 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP, Research and Development gave up 1,147 shares (to pay taxes)
  3. 4 Open-market sale Director sold 1,000 shares at $238.40 ($238,400)
  4. 4 Shares withheld for taxes EVP, HR gave up 474 shares (to pay taxes)
  5. 4 Open-market sale Director sold 250 shares at $237.99 ($59,498)
  6. 4 Grant or award Director acquired 16.93 shares (grant or award)
  7. 4 Open-market sale EVP, Gen. Counsel & Secy. sold 11,110 shares at $236.51 ($2,627,625)
  8. 4 Open-market sale Director sold 1,000 shares at $235.99 ($235,990)
  9. 4 Grant or award 10% owner acquired 25,762 shares (grant or award)
  10. 4 Grant or award 10% owner acquired 228,138 shares (grant or award)
  11. 4 Open-market sale Director sold 250 shares at $242.40 ($60,600)
  12. 4 Shares withheld for taxes EVP, Research and Development gave up 2,125 shares (to pay taxes)
  13. 4 Grant or award VP, Finance & CAO acquired 1,453 shares (grant or award)
  14. 4 Shares withheld for taxes EVP Global Commercial Ops gave up 6,269 shares (to pay taxes)
  15. 4 Grant or award Director acquired 140.77 shares (grant or award)
  16. 4 Grant or award 10% owner acquired 59,390 shares (grant or award)
  17. 4 Grant or award 10% owner acquired 123,566 shares (grant or award)
  18. 4 Grant or award 10% owner acquired 168,352 shares (grant or award)
  19. 4 Open-market sale Director sold 1,000 shares at $241.02 ($241,020)
  20. 4 Open-market sale Director sold 250 shares at $242.95 ($60,738)

Page 26 of 99 · 1,961 filings